The HCV is first identified; it soon becomes clear that an even higher proportion of people with hemophilia have been exposed to this virus, which can result in chronic liver disease.

NHF recognized that over 60% of America’s 20,000 people with hemophilia had contracted HIV.

Robert Lee Henry, NHF's founder, passes away.

Isolation of the genes controlling factor VII and von Willebrand's factor production. (Factor VII deficiency results in a rare form of hemophilia, but also may have broad applications in treating more common forms of hemophilia.)

Ryan White, a hemophilia patient, is diagnosed with AIDs after a blood transfusion at age 13.

The media reports that 70%-90% of hemophiliacs in the U.S. are infected with AIDS.

NHF's MASAC recommends use of heat-treated plasma concentrates in order to minimize the risk of transmission of HIV-I (human immunodefficiency virus).

CDC Morbidity and Mortality Weekly Report (MMWR) reported 72% of severe asymptomatic hemophiliac had antibody to LAV antigens using the Western blot test. This virus is now known to be a member of the HIV-1 group of viruses.

A research team led by Dr. Jay Toole successfully cloned the human gene for the production of the blood-clotting protein Factor VIII.

In 1984, Hemophilia of Michigan is appointed the federal Regional Core Center for Michigan, Ohio, and Indiana HTCs.